Douglas J Swirsky Insider Trading $GNVC GENVEC INC
Get free email notifications about insider trading for Douglas J Swirsky.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Douglas J Swirsky. Douglas J Swirsky is Director in Fibrocell Science, Inc. ($FCSC) and Director in PERNIX THERAPEUTICS HOLDINGS, INC. ($GTA) and Chief Financial Officer in GENVEC INC ($GNVC) and President & CEO in GENVEC INC ($GNVC) and President and CEO in GENVEC INC ($GNVC) and President and CEO in REXAHN PHARMACEUTICALS, INC. ($RNN) and President and CFO in REXAHN PHARMACEUTICALS, INC. ($RNN) and Director in Cellectar Biosciences, Inc. ($CLRB) and Director in NeuroBo Pharmaceuticals, Inc. ($GEMP).
Douglas J Swirsky in GENVEC INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Douglas J Swirsky: President and CEO, President & CEO, Chief Financial Officer
Holdings: 50,250 shares
Current Value: $321,600
Latest Transaction: Jun 20 2017
$GNVC Market Capitalization: $14.75M
$GNVC Previous Close: $6.40
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Douglas J Swirsky in GENVEC INC
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, CLRB, FCSC, GNVC, NRBO, RNN, GTA
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 20 2017 | GNVC | GENVEC INC | Swirsky Douglas J | President and CEO | Option Exercise | M | 5.60 | 25,000 | 140,000 | 0 | |
| Jun 20 2017 | GNVC | GENVEC INC | Swirsky Douglas J | President and CEO | Sell | D | 0.00 | 29,320 | 0 | 0 | 29.3 K to 0 (-100.00 %) |
| Jun 20 2017 | GNVC | GENVEC INC | Swirsky Douglas J | President and CEO | Payment of Exercise | F | 7.19 | 20,930 | 150,487 | 29,320 | 50.3 K to 29.3 K (-41.65 %) |
| Jun 20 2017 | GNVC | GENVEC INC | Swirsky Douglas J | President and CEO | Buy | M | 5.60 | 25,000 | 140,000 | 50,250 | 25.3 K to 50.3 K (+99.01 %) |
| Sep 16 2016 | GNVC | GENVEC INC | Swirsky Douglas J | President & CEO | Buy | P | 0.50 | 10,000 | 5,000 | 252,500 | 242.5 K to 252.5 K (+4.12 %) |
| Feb 01 2016 | GNVC | GENVEC INC | Swirsky Douglas J | President & CEO | Option Exercise | A | 0.56 | 250,000 | 140,000 | 250,000 | |
| Dec 15 2015 | GNVC | GENVEC INC | Swirsky Douglas J | President & CEO | Buy | P | 2.00 | 5,000 | 10,000 | 242,500 | 237.5 K to 242.5 K (+2.11 %) |
| Mar 19 2007 | GNVC | GENVEC INC | Swirsky Douglas J | Chief Financial Off ... | Buy | P | 2.52 | 5,000 | 12,600 | 5,000 | 0 to 5 K |
| Jan 22 2007 | GNVC | GENVEC INC | Swirsky Douglas J | Chief Financial Off ... | Option Exercise | A | 2.61 | 30,000 | 78,300 | 30,000 | |
| Sep 19 2006 | GNVC | GENVEC INC | Swirsky Douglas J | Chief Financial Off ... | Option Exercise | A | 1.13 | 300,000 | 339,000 | 300,000 | |
| Sep 19 2006 | GNVC | GENVEC INC | Swirsky Douglas J | Chief Financial Off ... | Option Exercise | A | 1.13 | 300,000 | 339,000 | 300,000 |
Page: 1